Updated for 2026 with CMS-0057-F rule, Medicare GLP-1 Bridge program, MFN pricing deals, oral Wegovy approval, and AHIP reform pledges
But I stopped last week because the medication caused malaise, fatigue, and muscle weakness
Metabolic alterations favor PDAC onset, which occurs early upon dysmetabolism
It also slows down evaporation, increasing contact time and ensuring complete microbial kill
These free thiols, which indicate systemic oxidative stress, showed a strong correlation with endoscopic disease activity and were more effective in distinguishing disease severity than fecal calprotectin levels
Hair loss is reported by some GLP-1 users, likely related to rapid weight loss and nutritional changes rather than the medication itself